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doi:10.1016/j.jmii.2011.12.008Background/Purpose: Acute mastoiditis has been increasingly reported. We reviewed our
experience of mastoiditis in children in the era of expanding application of imaging tools
and endless emerging antimicrobial resistance.
Methods: We reviewed all medical records of children (< 18 years of age) hospitalized with
mastoiditis between January 2001and December 2010. Diagnosis of mastoiditis was based on
clinical features and confirmed by imaging studies. Patients were classified as having acute
or nonacute mastoiditis according to the duration of the disease. Acute mastoiditis was defined
as illness of less than 3 weeks prior to hospitalization. Cases of longer than 3 weeks’ duration
were defined as nonacute mastoiditis. We compared the clinical, laboratory and microbiolog-
ical features of acute and nonacute mastoiditis.
Results: A total of 104 children were enrolled in this study, comprising 56 acute cases and 48
nonacute cases. Fever and coryza were significantly more common in acute cases. C-reactive
protein (CRP) and erythrocyte sedimentation rate (ESR) were both initially higher in acute
mastoiditis. CRP, rather than ESR, declined faster in acute than in nonacute mastoiditis.
Computerized tomography (CT) scans, but not plain films, were highly sensitive. Strepto-
coccus pneumoniae and Haemophilus influenzae accounted for 52% of all isolates. Staphylo-
cocci, Pseudomonas spp. and polymicrobials were predominantly seen in non-acute
mastoiditis.of Pediatrics, Veterans General Hospital-Kaohsiung, 386 Ta-Chung First Road, 813 Kaohsiung, Taiwan.
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378 J.-H. Chien et al.Conclusion: With the application of imaging studies, many cases of mastoiditis were identi-
fied. The classical postauricular signs were present in only 10% of patients. The presenting
symptoms, inflammatory markers, pathogens, management and outcome were greatly influ-
enced by the duration of the illness prior to admission.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
In the pre-antimicrobial era, mastoiditis was the most
common and feared complication of acute otitis media, and
caused significant and even life-threatening complications
beyond the tympanomastoid system, including sub-
periosteal abscess, Bezold’s abscess, facial paralysis,
suppurative labyrinthitis, meningitis, epidural and subdural
abscess, brain abscess, and lateral sinus thrombophlebitis.1
Since the introduction of antimicrobial therapy, incidence
of mastoiditis and its complications have markedly reduced.
However, an increase in incidence of acute mastoiditis has
been noted in recent reports.2,3 Mastoiditis is more common
in the pediatric age group, and most patients are younger
than 4 years of age.4e8 The typical local signs of acute
mastoiditis are postauricular pain, swelling, erythema and
tenderness9; however, these classical signs are less common
in the antimicrobial era, even in acute disease, which leads
to difficulty in and delay of the diagnosis.7
In a recent systemic review of diagnostic criteria for
acute mastoiditis in children, it was suggested that this
disease is poorly evaluated and understood and there is lack
of consensus regarding the criteria and strategies for
diagnosing acute mastoiditis in the pediatric population.10
To date only scanty clinical and microbiological data on
mastoiditis in children are available in Taiwan. Two reports
on mastoiditis in Taiwanese children have been published
over the past decade. Jiang et al reported 19 cases based
on physical, imaging (eight patients) and surgical (six
patients) findings and suggested that acute mastoiditis was
uncommon, but its complications were high.8 In their
series, 90.5% of cases had postauricular pain and over one-
third of cases had underlying diseases. In contrast, Cheng
et al reported that among 19 cases (15 patients underwent
imaging studies), only six patients (32%) had postauricular
swelling and tenderness.7 The article demonstrated a lack
of typical physical findings in most cases of mastoidits, and
thus the authors suggested that mastoiditis was often
overlooked by physicians.
The clinical spectrum and case definition of mastoiditis
in children has evolved overtime. The availability of anti-
biotic therapy, imaging studies and preventive vaccines has
had a great impact on the outcome and complications of
this disease. Clearly, mastoiditis in children is not well
understood and its clinical spectrum needs further delin-
eation. This report describes our clinical experiences on
104 children with mastoiditis confirmed by clinical and
computed tomography (CT) scans (97 patients) or plain
films of mastoid region (seven patients). It discusses diag-
nostic challenges and provides comparative data on clin-
ical, laboratory and microbiological features at acute and
nonacute stages of the illness, and shares our approach to
management of mastoiditis in children.Methods
This retrospective study reviewed medical records on all
patients less than 18 years of age who presented with the
clinical diagnosis of mastoiditis to the Kaohsiung Veterans
General Hospital (KVGH) from January 1, 2001 to December
31, 2010. The hospital is a tertiary referral medical center
with 1200 beds, including 130 beds in the Department of
Pediatrics, serving the population of Kaohsiung and
surrounding communities of southern Taiwan.
Diagnosis of mastoiditis was established by both clinical
features and imaging studies. Clinical features of mastoid-
itis included: fever, otalgia, otorrhea, postauricular
inflammation (swelling, redness, tenderness) and anterio-
inferior displacement of auricle, eardrum abnormalities,
and other nonspecific signs such as coryza, vomiting and
poor appetite (Table 1). An increased soft tissue density in
the mastoid air sinus by plain films or CT image was
considered a positive finding. Patients with any one of the
above clinical features plus positive findings on CT scan or
plain films of mastoid region were enrolled in our study.
Indications for obtaining imaging studies were based
primarily on the judgment of the attending physicians.
Patients with incomplete data or in whom the diagnosis was
not conclusive were excluded. A total of 104 children
meeting the diagnostic criteria were enrolled in this study.
The clinical course and spectrum of mastoiditis are
poorly understood. Most papers refer to this clinical entity
as “acute” mastoiditis. Clinical data on “subacute” or
“chronic” mastoiditis are very limited. In contrast, otitis
media is traditionally classified as acute (<3 weeks),
subacute (3 weeks to 3 months) and chronic (>3 months)
according to the clinical course of the disease.11 In this
study, we modeled otitis media and classified mastoiditis
into acute (<3 weeks) or nonacute (>3 weeks) cases based
on the duration of the disease (from onset of the illness to
the time of diagnosis). We examined and compared the
differences in clinical features, inflammatory markers,
bacterial pathogens, and outcome between acute and
nonacute mastoiditis. Recurrence within 3 months after
completion of antibiotic therapy was defined as relapse;
recurrence after 3 months was defined as reinfection.
Relapse was considered to be the same episode as the
previously recognized disease, and was regarded as treat-
ment failure, while reinfection suggested a distinct
episode. Images, microbiological and laboratory data,
antimicrobial selection, medical or surgical intervention,
and outcomes were also reviewed and recorded in a stan-
dard form.
The magnitudes of change in inflammatory markers, i.e.,
erythrocyte sedimentation rate (ESR), C-reactive protein
(CRP), leukocyte and neutrophil counts) during therapy
were analyzed. The mean daily decrement of CRP or ESR,
Table 1 Inflammatory markers and clinical features at presentation in 104 children with acute or nonacute mastoiditis
Inflammatory markers Acute cases Nonacute cases p
Median (25e75% quartile range) Median (25e75% quartile range)
CRP (mg/dL) 3.35 (1.17e10.43) 1.00 (0.32e4.10) 0.015
ESR (mm/h) 62.00 (27.00e88.50) 25.00 (6.00e42.50) 0.040
Mean neutrophils (%) 60% 56% 0.295
Mean daily CRP decrement 25.6% 20.8% 0.034
Mean daily ESR decrement 4.5% 6.5% 0.903
Clinical features No. of patients (%) No. of patients (%)
Fever 53 (95%) 39 (81%) 0.033
Coryza 35 (63%) 19 (40%) 0.024
Otalgia 25 (45%) 16 (33%) 0.239
Vomiting 8 (14%) 2 (4%) 0.103
Otorrhea 19 (34%) 16 (33%) 0.147
Congested eardrum 56 (100%) 48 (100%) 1.000
Poor appetite 10 (18%) 9 (19%) 0.906
Postauricular pain 7 (13%) 4 (8%) 0.491
CRP Z C-reactive protein; ESR Z erythrocyte sedimentation rate.
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was calculated (i.e., first CRP or ESR values minus second
CRP or ESR values divided by the number of days in the
interval).
Statistical analysis
All categorical variables were analyzed using c2 test or
Fisher’s exact test as appropriate, and continuous variables
by the Student t test. The result was considered to be
significant if a two-tailed p value was less than 0.05. The
tool for data analysis was SPSS 17.0 for Windows (SPSS Inc.
Chicago, USA).
Results
Of the 104 children with mastoiditis enrolled in this study,
there were 46 females and 58 males. The mean age was
3.58 years (range: 7 months to 12 years of age). Seventy-
three patients (70%) were younger than 4 years of age.
Fifty-six cases (54%) were assessed as acute mastoiditis,
and 48 cases (46%) were assessed as nonacute mastoiditis.
Thirty-four cases (33%) were unilateral, and 70 cases (67%)
had bilateral involvement. All patients with mastoiditis had
middle ear infection, regardless of whether disease was
acute or nonacute.
Laboratory and clinical features
Inflammatory markers and clinical presentations are
summarized in Table 1. The initial median CRP values at the
time of hospitalization were significantly higher in acute
mastoiditis as compared to nonacute mastoiditis (3.35 mg/L
vs. 1.00 mg/L, pZ 0.015). Similarly, ESR values were higher
in acute cases than in nonacute cases (62 mm/hour vs.
25 mm/hour, p Z 0.040). During therapy, mean daily CRP
declined significantly faster in acute cases than in nonacute
cases (25.6 % vs. 20.8%, p Z 0.034). ESR also declined inboth acute and nonacute mastoiditis, but in much slower
rates (mean daily decrement: 4.5% vs. 6.5%). Neutrophil
percentage and total leukocyte count did not show differ-
ences between these two groups, regardless of the initial
measurement or the rate of decline.
As showed in Table 1, there were some differences in
clinical features between acute and nonacute cases. For
example, fever and coryza were more common in acute
cases than in nonacute cases: fever (95% vs. 81%,
p Z 0.033) and coryza (63% vs. 40%, p Z 0.024). In
contrast, otolgia and otorrhea occurred in less than 50% of
the patients in both groups and without significant differ-
ence. Postauricular pain, swelling, erythema or tenderness
was less common in both groups (13% vs. 8%). All patients
had signs of otitis media, including bulging drums,
erythematous changes ruptured membranes or otorrhea.
Nineteen patients (18%) had history of allergies, including
rhinitis (11), asthma (five) and three with both conditions.
Eleven of these 19 patients were nonacute cases and eight
were acute cases.
Imaging and radiographic features
Ninety-seven of 104 patients (93%) underwent examinations
by CT scans of the inner petrous pyramids region. All had
soft tissue density instead of air, in the mastoid air cells,
suggestive of mastoiditis. The other seven patients were
diagnosed with mastoiditis by plain films only. Of the 31
patients who received both CT scans and plain film exami-
nations, all showed positive findings by CT scans, but only
20 (65%) by plain films.
Microbiological studies
Blood cultures were performed in 88 patients. Only three
patients (3%) revealed bacteremia, uniformly caused by
Streptococcus pneumoniae. Other cultures were obtained
from 49 patients: ear drainages (29 patients) and surgical
specimens (20 patients, including 19 myringotomy, and one
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gens isolated from patients with acute and nonacute
mastoiditis.
Of the 49 patients, 35 gave positive microbiologic results
(71%). S. pneumoniae was isolated in 15 and Haemophilus
influenzae in seven patients (including in the polymicrobial
group). S. pneumoniae andH. influenzae accounted for 52%of
all isolates. All S. pneumoniae strains were susceptible to
clindamycin, cefotaxime and vancomycin. Twelve (79%)
S. pneumoniae strains were sensitive to penicillin with
minimum inhibitory concentration (MIC& 2 mg/mL. None of
the strains had MIC S 8 mg/mL. Five H. influenzae isolates
were belactamase producers (71%). Isolates from surgical
specimens included four strains of S. pneumoniae, four strains
of meticillin-resistant Staphylococcus aureus (MRSA) and
seven strains of Pseudomonas aeruginosa. Staphylococcus
spp. were isolated in 10 cases: with six MRSA strains (two in
acute disease, and four in non-acute disease), two meticillin-
sensitive strains and two coagulase-negative Staphylococcus
strains. Ten patients had P. aeruginosa, of whom nine had
nonacute mastoiditis. As expected, MRSA, P. aeruginosa and
polymicrobial isolates were significantly more common in
nonacute mastoiditis. All of the P. aeruginosa strains were
susceptible to amikacin, ceftazidime, cefepime, cipro-
floxacin, levofloxacin, imipenem and piperacillin.
Management and outcome
Our initial antibiotic approach to mastoiditis included
intravenous amoxicillin/clavulanate or ampicillin/sulbac-
tam. Anti-Pseudomonas agents or glycopeptides were
added, as needed, when culture information become avail-
able. In this study, 20 patients (19%) underwent surgical
intervention, including 19 myringotomy with ventilation
tube placement, and one cortical mastoidectomy.
One of 56 patients (2%) had a relapse of infection in the
acute mastoiditis group, whereas eight of 48 patients (17%)
had a relapse in the nonacute mastoiditis group (p < 0.001).Table 2 Bacterial pathogens isolated by cultures of ear







Streptococcus pneumoniae 8 7 0.966










Pseudomonas aeruginosa 1 9 0.005
Polymicrobiala 2 9 0.012
a The number of isolates including those of polymicrobial
infection. Components of polymicrobial infection in acute
mastoiditis included H. influenzae with positive b-lactamase
and MRSA. Nine polymicrobial infections in nonacute mastoiditis
included: S. pneumoniae (n Z 6), H. influenzae (n Z 3), MRSA
(nZ 3), P. aeruginosa (nZ 4) and Achromobacter spp. (nZ 2).All relapses occurred within 3 months of completion of
therapy. Among 48 nonacute cases, the relapse rate was
11% in the surgical intervention group and 21% in the
nonsurgical intervention group (p Z 0.451).
Twenty-nine (28%) of our patients had hearing impair-
ment at the time of admission, and five of them had
residual hearing impairment at follow-up evaluations.Discussion
The mastoid is contiguous to the middle ear cleft. Infection
of the middle ear has the potential to spread to the mastoid
air cells and beyond. The term “mastoiditis” elicits alarm
among those who care for the patient. Furthermore, the
terminology applied to mastoiditis is vague; for example:
incipient mastoiditis, coalescent mastoiditis, surgical mas-
toditis, acute, subacute or chronic mastoiditis. The clinical
spectrum of mastoiditis and natural history of the disease
are not well understood. There is lack of consensus on
current diagnostic criteria.10,12
Published data from Taiwan on mastoiditis in children
have been limited to two retrospective reports involving
a total of 38 patients over the past decade.7,8 Our retro-
spective study on 104 children with mastoiditis offers
a unique opportunity to re-examine the clinical spectrum
and diagnostic challenges. We found that the disease is not
uncommon and that duration of the illness (i.e., under or
over 3 weeks) prior to hospitalization had a significant
influence on clinical presentation, level of inflammatory
markers, type of bacterial pathogens, antibiotic choice,
and disease relapse. Our observations, although not novel
or unexpected, represent a rare attempt to compare the
differences between patients with acute and nonacute
disease, and provide further information relevant to diag-
nosis and management of mastoiditis in children.
For many decades, postauricular symptoms and signs
(i.e., pain, swelling, redness, tenderness and anteroinferior
displacement of the auricle) have been used as major clues
for clinical diagnosis of mastoiditis in children.3,6,9,13 Our
experience differs somewhat from these published reports.
The present report confirms our previous observations that
most children with mastoiditis, confirmed by CT scans, did
not demonstrate the typical postauricular signs.7
CT scanning of the temporal bone has been generally
recommended for the evaluation of mastoiditis. A recent
review of published data on mastoiditis indicated that CT
scanning was performed in 68% of patients with mastoid-
itis.10 CT findings of mastoiditis vary with the stage of the
infection, and usually include opacification of the mastoid
cells, loss of sharpness or visibility of the mastoid cell walls,
haziness or distortion of the mastoid outline, enhancement
of areas of abscess formation, elevation of periosteum of
mastoid process or posterior cranial fossa, and osteoblastic
activity in chronic mastoiditis. CT scanning is very sensitive
in detecting changes of mastoiditis, but its specificity is not
well evaluated. Based on histopathological findings, Staheli-
Massik et al reported that CT scanning had a sensitivity of
100% and specificity of 38%.14 In studying the correlation
between CT scan and surgical findings, Migirv reported that
CT scanning had a sensitivity of 97% and a predictive value of
94%. Others have reported sensitivity of 80e100%.15
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received a CT scan. Among those who received only the less
sensitive plain x-ray studies, some patients might not have
been identified and enrolled in the study (underdiagnosis).
On the other hand, among those who received the highly
sensitive and less specific CT scans, some patients might
have been falsely identified and enrolled (overdiagnosis).
Since mastoid air cells are in continuity with the middle ear
cavity, children with acute otitis media may be associated
with mucosal inflammation in the mastoid air cells (asymp-
tomatic or incipient “mastoiditis”). The number of under- or
overdiagnosed mastoiditis in our series is unknown.
Our microbiological findings were not unexpected. S.
pneumoniae and H. influenzae accounted for over half of
all bacterial isolates and were evenly distributed among the
acute and nonacute cases. In contrast, Staphylococcus,
Pseudomonas and polymicrobials were predominantly seen
in the nonacute cases. Others have found Streptococcus
pyogenes as an important pathogen in mastoiditis in chil-
dren, but none of our patients had S. pyogenes.
There are two major deficiencies in our microbiological
studies: not all patients had adequate specimens for cultures
and insufficient information from mastoid aspiration or
tympanocentesis (except the 19 patients who underwent
myringotomy). MRSA and Pseudomonas spp. were more often
isolated from surgical than nonsurgical specimens: surgical
(four MRSA, seven Pseudomonas) versus nonsurgical (two
MRSA, three Pseudomonas). Overall P. aeruginosa and poly-
microbials were significantly more common in nonacute
mastoiditis. MRSA was also more common in nonacute cases,
but this difference was not statistically significant. The
precise role of Staphylococcus, Pseudomonas and poly-
microbial agents in our nonacute patients remains to be
determined. Some are from surgical specimens, but some
are likely colonization or contamination. Their pathogenic
role in nonacute cases of mastoiditis cannot be excluded
with certainty. Mastoiditidis with meningitis caused by
P. aeruginosa has been reported in Taiwan.8
Undoubtedly antibiotic therapy prior to admission had
a major effect on the clinical course of mastoiditis. Others
have reported as high as 80e100% of patients were under
antibiotic treatment prior to admission.3,6 In our series,
history indicated that most patients were on medications of
unspecified nature prior to hospitalization. From the records
we were able to identify only a relatively small number of
patients on specific antibiotics: ampicillin/amoxicillin (nine),
ampicillinesulbactam/amoxicillineclavulanate (nine), mac-
rolide (two) and cephalexin (two). The number is too small to
determine the correlation between antibiotic consumption
and bacterial isolation from patients.
Our knowledge about mastoiditis in children has been
acquired over many decades covering the pre- and postanti-
biotic era, mostly by retrospective studies. With the intro-
duction of imaging modality, our view about the disease and
approach to this infection are changing. The emergence of
antibiotic-resistant bacteria and increasing application
of conjugated vaccines for S. pneumoniae and H influenzae
type b will undoubtedly alter the patterns of the disease and
our approach to this infection. Our retrospective review, as in
most published papers on mastoiditis in children, has many
inherent limitations and deficiencies as discussed. Mastoiditis
will continue to evolve as we enter the era of increasingpressure from antibiotic-resistant microbes. It will require
well-designed prospective studies to evaluate its clinical
spectrum, microbiological features, approach to diagnosis
and management, and long-term follow-up of this poorly
understood and underevaluated disease that continues to
alarm parents and physicians.
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